Clinical Trial Update: Treatment-free Remission Accomplished With Dasatinib in Patients With CML [Phase 2]

View source ↗

Summary

Phase 2 trial reporting treatment-free remission achieved with dasatinib in chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: UNKNOWN